Join to View Full Profile
675 N St Clair StSuite 21-100Chicago, IL 60611
Phone+1 312-695-0990
Fax+1 312-695-1144
Dr. Pollack is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a medical oncologist and specialize in treating adult patients with sarcoma. My research is focused on the development of novel immunotherapies for patients with advanced sarcoma, particularly Synovial Sarcoma (SS) and Myxoid/Round Cell Liposarcoma (MRCL). My patient care philosophy is to provide care centered on my patients goals and desires and to fight as hard as I can to help cure my patients.
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2008 - 2010
George Washington UniversityResidency, Internal Medicine, 2005 - 2008- George Washington University School of Medicine and Health SciencesClass of 2005
Haverford CollegeBachelor of Arts, Mathematics, 1995 - 1999
Certifications & Licensure
FL State Medical License 2025 - Present
IL State Medical License 2020 - 2026
WA State Medical License 2008 - 2022
VA State Medical License 2005 - 2008
DC State Medical License 2005 - 2007
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Sig Kohl Legacy Award Northwest Sarcoma Foundation, 2017
Clinical Trials
- Autologous T Cells and Cyclophosphamide in Treating Patients With Soft Tissue Sarcoma That is Metastatic or Cannot Be Removed By Surgery Start of enrollment: 2012 Jan 01
- Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma Start of enrollment: 2013 Sep 25
- NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma Start of enrollment: 2014 Jul 01
Publications & Presentations
PubMed
- Revisiting the Immune Frontier in Soft Tissue Sarcomas.Nadeem Bilani, Nourhane Al Akoum, Rusul Al-Marayaty, Sarah Orlando, Borislav Alexiev
Current Oncology Reports. 2026-03-17 - Performance of deep learning-based segmentation of soft tissue sarcoma by MRI sequence, tumor type and location.Linkai Peng, Laetitia Perronne, Nicolò Gennaro, Ahmad Pour Rashidi, Zuzanna Kobus
Skeletal Radiology. 2026-03-04 - Potent cytotoxic tumor-infiltrating lymphocytes can be generated from immune-excluded chondrosarcomas using regulatable membrane-bound IL15.Zheng Ao, Rusul Al-Marayaty, Bülent Arman Aksoy, Farres Obeidin, Rachel Burga
Cancer Immunology Research. 2026-02-20
Press Mentions
Exploring the Use of Weakened Viruses for Cancer TreatmentJune 12th, 2024
SCCA’s Immunotherapy Leaders Featured at the American Society of Clinical Oncology (ASCO) Annual MeetingMay 31st, 2018
Can You Vaccinate Yourself Against Cancer?February 21st, 2018
Grant Support
- Targeting MIC to Augment Adoptive NK Therapy Using the Canine Soft Tissue Sarcoma ModelNORTHWESTERN UNIVERSITY AT CHICAGO2025–2030
- Improving Mucosal Melanoma Therapy by Harnessing the Immunogenicity of r3LCMVNORTHWESTERN UNIVERSITY AT CHICAGO2025–2029
- Special Public T Cell Receptor Sequences that Predict Outcomes for Cancer PatientsNORTHWESTERN UNIVERSITY AT CHICAGO2023–2025
- Novel IL-12 Gene Delivery Vehicles for Transformation of Solid TumorsNORTHWESTERN UNIVERSITY AT CHICAGO2019–2024
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
